DrugPatentWatch Database Preview
Hydralazine hydrochloride; hydrochlorothiazide - Generic Drug Details
What are the generic drug sources for hydralazine hydrochloride; hydrochlorothiazide and what is the scope of hydralazine hydrochloride; hydrochlorothiazide patent protection?
Hydralazine hydrochloride; hydrochlorothiazide
is the generic ingredient in twenty-one branded drugs marketed by Novartis, Par Pharm, Solvay, Superpharm, Watson Labs, Ivax Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Sandoz, Sun Pharm Industries, and Lederle, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-one drug master file entries for hydralazine hydrochloride; hydrochlorothiazide.
Summary for hydralazine hydrochloride; hydrochlorothiazide
US Patents: | 0 |
Tradenames: | 21 |
Applicants: | 12 |
NDAs: | 36 |
Drug Master File Entries: | 21 |
Bulk Api Vendors: | 1 |
Clinical Trials: | 3 |
DailyMed Link: | hydralazine hydrochloride; hydrochlorothiazide at DailyMed |
Synonyms for hydralazine hydrochloride; hydrochlorothiazide
C8H8N4.C7H8ClN3O4S2.HCl |
LS-178474 |
SCHEMBL9374288 |